Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 10, 2020 (7 years ago)

Buprenorphine Watermelon 8 mg Troche

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Buprenorphine Watermelon 8 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida

Drug: Buprenorphine

Recalling firm
Matthew 7:25 Inc dba Thrive Pharmacy
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1053-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Buprenorphine recalls

See all
Class II · Moderate risk

Buprenorphine HCl

Crystallization; identified as Buprenorphine free base

Ongoing Failed specification Par Health USA, LLC NDC 42023-179-05 D-0596-2026

Other recalls by Matthew 7:25 Inc dba Thrive Pharmacy

All 2020 recalls